These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3970729)

  • 1. Trihexyphenidyl--further evidence for muscarinic receptor subclassification.
    Tien XY; Wallace LJ
    Biochem Pharmacol; 1985 Feb; 34(4):588-90. PubMed ID: 3970729
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interactions of gallamine with muscarinic receptors from brain.
    Ellis J; Lenox RH
    Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
    [No Abstract]   [Full Text] [Related]  

  • 6. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge but not chemical class explains the selective binding of [3H]N-methylscopolamine to a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates.
    Lee NH; Ramkumar V; el-Fakahany EE
    Eur J Pharmacol; 1986 Oct; 130(1-2):153-5. PubMed ID: 3780857
    [No Abstract]   [Full Text] [Related]  

  • 8. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
    Lee JH; el-Fakahany EE
    Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of muscarinic acetylcholine receptors in wild type and cholinergic mutants of Caenorhabditis elegans.
    Culotti JG; Klein WL
    J Neurosci; 1983 Feb; 3(2):359-68. PubMed ID: 6822867
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of iodinated quinuclidinyl benzilate enantiomers with M3 muscarinic receptors.
    Hiramatsu Y; Eckelman WC; Baum BJ
    Life Sci; 1994; 54(23):1777-83. PubMed ID: 8196491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ; Delen FM
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.
    Baumgold J; Cohen VI; Paek R; Reba RC
    Life Sci; 1991; 48(24):2325-9. PubMed ID: 2046461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.
    Kimura Y; Ohue M; Kitaura T; Kihira K
    Brain Res; 1999 Jul; 834(1-2):6-12. PubMed ID: 10407088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.